Vincerx Pharma, Inc.
Vincerx Pharma, Inc.（VINC）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
vinc · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年5月30日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$4.00
Consensus
$3.00
+22713.7% upside
Low
$2.00
Median: $3 · Last Close: $0.01
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.01 | ↓ 2.24% |
1-day model range: $0.01–$0.01. Peak: $0.01 (-2.24%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · VINC · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-10-08 | Leerink Partners | Maintains | Outperform→Outperform |
| 2023-09-07 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-11-17 | Chardan Capital | Maintains | Buy→Buy |
| 2022-08-12 | SVB Leerink | Maintains | Outperform→Outperform |
| 2022-06-08 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-06-07 | Chardan Capital | Maintains | Buy→Buy |
| 2022-06-07 | B. Riley Securities | Maintains | Buy→Buy |
| 2022-06-07 | SVB Leerink | Maintains | Outperform→Outperform |
| 2022-05-13 | Chardan Capital | Maintains | Buy→Buy |
| 2022-05-13 | SVB Leerink | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Vincerx Pharma, Inc. (VINC) stock. Of the recent 19 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover VINC.
分析师推荐趋势
VINC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$18M
EPS This Year
$-15.60
EPS Next Year
$-12.00
↓ 23.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast VINC EPS of $-15.60 for the current fiscal year, based on estimates from 1 analysts. The VINC revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
VINC 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。VINC 的共识目标价为 $3.00（+22713.7% 上行空间），分析师共识为 Buy。
VINC 的短期预测（明日）为 $0.01（-2.24%）。
Vincerx Pharma, Inc. 在 OTC 上市，代码 VINC。VINC 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
VINC 预测 · 8 个问题根据 7 位华尔街分析师，VINC 的 12 个月平均目标价为 $3.00，最高 $4.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $0.01，隐含约 +22713.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.